Baku: A presentation event dedicated to the implementation of the SATLARS T8 technology was held at the Laboratory of the Central Customs Hospital on April 23. The event was attended by Head of the Central Customs Hospital – Chief Physician Bakhtiyar Musayev, Head of the Laboratory Department Sabina Ibrahimova, laboratory physicians, and media representatives.
According to Azerbaijan State News Agency, the introduction of the SATLARS T8 technology marks a significant advancement in laboratory diagnostics, aiming to enhance service efficiency and elevate the accuracy and speed of medical care for patients. The technology facilitates the integration of all laboratory processes into a unified system, which is crucial for modern laboratory operations.
The SATLARS T8 platform, developed by Shenzhen New Industries Biomedical Engineering Co., Ltd in China, stands out as a leading innovation in laboratory diagnostics. The technology is utilized in over 160 countries, signifying its reliability and technological sophistication, along with a robust international reputation.
The SATLARS T8 system includes the MAGLUMI X8 and the Bioassay C8 platforms. The MAGLUMI X8 is a chemiluminescence immunoassay analyzer that enhances diagnostic precision and supports clinical decision-making with an extensive test menu and high throughput. The Bioassay C8 is an automated biochemical analyzer designed for high-precision and consistent biochemical testing.
By integrating these systems, the SATLARS T8 enables parallel analysis, streamlines workflow, and ensures rapid result delivery. Additionally, the systems are supported by external quality control programs aligned with international standards, further assuring the dependability and precision of laboratory outcomes.
The Central Customs Hospital remains committed to advancing the quality of medical services through the adoption of cutting-edge technologies and international best practices.